SKF-89976A: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
== SKF-89976A == | |||
<gallery> | |||
File:SKF-89976A.svg|SKF-89976A | |||
File:SKF-89976A_synthesis.svg|SKF-89976A synthesis | |||
File:NNC-47-0011.svg|NNC-47-0011 | |||
</gallery> | |||
Latest revision as of 20:54, 25 February 2025
SKF-89976A is a GABA transporter 1 inhibitor which is used in scientific research. It has anticonvulsant effects and may be useful in the treatment of epilepsy. SKF-89976A has also been suggested as a possible treatment for schizophrenia and dementia.
Mechanism of action[edit]
SKF-89976A works by inhibiting the GABA transporter 1 (GAT1), a protein that is responsible for the reuptake of GABA in the brain. By inhibiting this transporter, SKF-89976A increases the amount of GABA available in the brain, which can have a variety of effects.
Uses[edit]
SKF-89976A has been used in scientific research to study the role of GABA in the brain and its potential as a treatment for various conditions. It has been found to have anticonvulsant effects, suggesting it may be useful in the treatment of epilepsy. In addition, it has been suggested as a possible treatment for schizophrenia and dementia, although more research is needed in these areas.
Side effects[edit]
As with any drug, SKF-89976A can have side effects. These can include nausea, vomiting, and dizziness. However, these side effects are generally mild and go away on their own.
